C
Cristina Morelli
Researcher at University of Rome Tor Vergata
Publications - 18
Citations - 135
Cristina Morelli is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Cancer & Oxaliplatin. The author has an hindex of 5, co-authored 18 publications receiving 76 citations.
Papers
More filters
Journal ArticleDOI
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2.
Vincenzo Formica,Marilena Minieri,Sergio Bernardini,Marco Ciotti,Cartesio D'Agostini,Mario Roselli,Massimo Andreoni,Cristina Morelli,Giusy Parisi,Massimo Federici,Carla Paganelli,Jacopo M. Legramante +11 more
TL;DR: In this article, the authors retrospectively reviewed consecutive patients presenting to the emergency department with symptoms suggestive of COVID-19 and undergoing swab tests for SARS-CoV-2.
Journal ArticleDOI
Biological and predictive role of ERCC1 polymorphisms in cancer
Vincenzo Formica,Elena Doldo,F.R. Antonetti,A. Nardecchia,Patrizia Ferroni,Silvia Riondino,Silvia Riondino,Cristina Morelli,H-T. Arkenau,Fiorella Guadagni,Augusto Orlandi,Mario Roselli +11 more
TL;DR: In this paper, the authors reviewed available evidence on the clinical role and utility of ERCC1 polymorphisms and, in the absence of a 'perfect' trial, what they call the "sliding doors" trial, they presented the data of ERcc1 genotyping in their local patient population.
Journal ArticleDOI
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
Vincenzo Formica,Cristina Morelli,Patrizia Ferroni,A. Nardecchia,Manfredi Tesauro,Stefania Pellicori,Vittore Cereda,Antonio Russo,Silvia Riondino,Fiorella Guadagni,Mario Roselli +10 more
TL;DR: NLR is both an independent prognostic and predictive factor in metastatic PDA, since only patients with high NLR seem to benefit from the addition of oxaliplatin.
Journal ArticleDOI
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors
Vincenzo Formica,Cristina Morelli,Anna Patrikidou,C. Murias,Sabeeh Butt,A. Nardecchia,Jessica Lucchetti,Nicola Renzi,Kai-Keen Shiu,Mario Roselli,Hendrik-Tobias Arkenau +10 more
TL;DR: GIPI, combining NLR, CRP, and albumin, is the first inflammatory index with a significant prognostic value in patients with mOGJ/GC receiving ICIs and merits validation in independent cohorts and prospective clinical trials.
Journal ArticleDOI
Obesity and common pathways of cancer and cardiovascular disease
Vincenzo Formica,Cristina Morelli,Silvia Riondino,Nicola Renzi,D. Nitti,N. Di Daniele,Mario Roselli,Manfredi Tesauro +7 more
TL;DR: Main common biological pathways linking obesity with cardiovascular diseases and cancer are summarized in order to provide a research framework within which therapeutic strategies might have at the same time cardiovascular-protective and cancer-preventive effects.